Showing results (731-740 of 809) with videos related to

Sort By:
Pageof 81
Prehospital Emergency Care|April 8, 2022
A Geospatial Evaluation of 9-1-1 Ambulance Transports for Children and Emergency Department Pediatric ReadinessCraig D Newgard, Susan Malveau, N Clay Mann, et al.
Theranostics|January 8, 2025
Millisecond-level transient heating and temperature monitoring technique for ultrasound-induced thermal strain imagingMengyue Chen, Zhiyu Sheng, Ran Wei, et al.
International Immunopharmacology|September 28, 2024
Spatial transcriptomics reveal tumor microenvironment and SLCO2A1 correlated with tumor suppression in hypopharyngeal squamous cell carcinomaCe Li, Chenyang Xu, Rui Guan, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|June 14, 2018
Investigation on Ehrlichia Infection in Small Mammals and Ticks from Tengchong, Yunnan Province, Southern ChinaChun-Hong Du, Hong-Bo Liu, Ran Wei, et al.
Frontiers in Pharmacology|May 15, 2023
Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsisChao-Yang Chen, Min Xie, Jun Gong, et al.
Cell Reports|November 27, 2025
CD8<sup>+</sup>MT<sup>+</sup> effector T cells from enlarged tumor-draining lymph nodes enhanced anti-tumor immunity and improved prognosis in colorectal cancerTiantongfei Jiang, Xu Guan, Ran Wei, et al.
Behavior Genetics|January 31, 2016
Tspyl2 Loss-of-Function Causes Neurodevelopmental Brain and Behavior Abnormalities in MiceQi Li, Siu Yuen Chan, Kwun K Wong, et al.
Diabetes/Metabolism Research and Reviews|October 23, 2024
Deep Contrast Clustering Analysis to Distinguish Diabetic Complications in Elderly Chinese PatientsWeihao Wang, Ran Wei, Pei Xiao, et al.
Discover Oncology|December 31, 2025
Pan cohort immune biomarker of CD8 lymphocyte activation enabling HGSOC outcome prediction and treatment responseXinkui Liu, Zhen Zhang, Bin Wang, et al.
Chronic Diseases and Translational Medicine|March 7, 2024
Adaptive ultra-hypofractionated whole-pelvic radiotherapy in high-risk and very high-risk prostate cancer on 1.5-Tesla MR-Linac: Estimated delivered dose and early toxicity resultsLinrui Gao, Ran Wei, Shirui Qin, et al.
Pageof 81